These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1445465)

  • 1. T cell activation through CD3 molecules in patients with systemic lupus erythematosus.
    Kaneoka H
    Arthritis Rheum; 1992 Nov; 35(11):1401-2. PubMed ID: 1445465
    [No Abstract]   [Full Text] [Related]  

  • 2. Abnormal early TCR/CD3-mediated signaling events of a snRNP-autoreactive lupus T cell clone.
    Liossis SN; Hoffman RW; Tsokos GC
    Clin Immunol Immunopathol; 1998 Sep; 88(3):305-10. PubMed ID: 9743618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective CD3-mediated cell death in activated T cells from patients with systemic lupus erythematosus: role of decreased intracellular TNF-alpha.
    Kovacs B; Vassilopoulos D; Vogelgesang SA; Tsokos GC
    Clin Immunol Immunopathol; 1996 Dec; 81(3):293-302. PubMed ID: 8938108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B7/BB1 provides an important costimulatory signal for CD3-mediated T lymphocyte proliferation in patients with systemic lupus erythematosus (SLE).
    Sfikakis PP; Oglesby R; Sfikakis P; Tsokos GC
    Clin Exp Immunol; 1994 Apr; 96(1):8-14. PubMed ID: 7512010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced CD3-mediated T lymphocyte proliferation in patients with systemic lupus erythematosus.
    Stekman IL; Blasini AM; Leon-Ponte M; Baroja ML; Abadi I; Rodriguez MA
    Arthritis Rheum; 1991 Apr; 34(4):459-67. PubMed ID: 1826426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal pattern of tyrosine phosphorylation in unstimulated peripheral blood T lymphocytes from patients with systemic lupus erythematosus.
    Blasini AM; Alonzo E; Chacón R; Riera R; Stekman IL; Rodriguez MA
    Lupus; 1998; 7(8):515-23. PubMed ID: 9863892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of T lymphocytes in systemic lupus erythematosus].
    Zubler RH; Miescher PA
    Ann Med Interne (Paris); 1990; 141(3):208-12. PubMed ID: 2195945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interferon therapy effects on activation of T-lymphocytes in patients with systemic lupus erythematosus].
    Stanislav ML; Balabanova RM; Nikonova MF; Litvina MM; Iarilin AA
    Ter Arkh; 2000; 72(5):44-9. PubMed ID: 11109620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [B-lymphocyte hyperreactivity and differentiation factors of T-lymphocytes in systemic lupus erythematosus].
    Humbert M; Galanaud P
    Ann Med Interne (Paris); 1990; 141(3):213-6. PubMed ID: 2369009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic lupus erythematosus: new molecular targets.
    Crispín JC; Kyttaris V; Juang YT; Tsokos GC
    Ann Rheum Dis; 2007 Nov; 66 Suppl 3(Suppl 3):iii65-9. PubMed ID: 17934100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linker for activation of T cells is displaced from lipid rafts and decreases in lupus T cells after activation via the TCR/CD3 pathway.
    Abdoel N; Brun S; Bracho C; Rodríguez MA; Blasini AM
    Clin Immunol; 2012 Mar; 142(3):243-51. PubMed ID: 22285373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The T cell enigma in lupus.
    Dayal AK; Kammer GM
    Arthritis Rheum; 1996 Jan; 39(1):23-33. PubMed ID: 8546735
    [No Abstract]   [Full Text] [Related]  

  • 13. Roles of CD147 on T lymphocytes activation and MMP-9 secretion in systemic lupus erythematosus.
    Pistol G; Matache C; Calugaru A; Stavaru C; Tanaseanu S; Ionescu R; Dumitrache S; Stefanescu M
    J Cell Mol Med; 2007; 11(2):339-48. PubMed ID: 17488482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The classical and alternative pathways of T-lymphocyte activation in patients with systemic lupus erythematosus].
    Stanislav ML; Balabanova RM; Nikonova MF; Litvina MM; Iarilin AA
    Ter Arkh; 1999; 71(5):30-4. PubMed ID: 10399227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Systemic lupus erythematosus].
    Takeuchi T; Tsuzaka K; Abe T
    Ryumachi; 1999 Aug; 39(4):679-87. PubMed ID: 10536486
    [No Abstract]   [Full Text] [Related]  

  • 16. Defective proliferative response of T lymphocytes from patients with inactive systemic lupus erythematosus.
    Hernández-Fuentes MP; Reyes E; Prieto A; Zea A; Villa L; Sánchez-Atrio A; Esquivel F; Alvarez-Mon M
    J Rheumatol; 1999 Jul; 26(7):1518-26. PubMed ID: 10405939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective early T and T-dependent B cell activation in systemic lupus erythematosus.
    Fernández-Gutiérrez B; de Miguel S; Morado C; Hernández-García C; Bañares A; Jover JA
    Lupus; 1998; 7(5):314-22. PubMed ID: 9696135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA microarray gene expression profile of T cells with the splice variants of TCRzeta mRNA observed in systemic lupus erythematosus.
    Tsuzaka K; Nozaki K; Kumazawa C; Shiraishi K; Setoyama Y; Yoshimoto K; Suzuki K; Abe T; Takeuchi T
    J Immunol; 2006 Jan; 176(2):949-56. PubMed ID: 16393980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphopenia relating to T-lymphocyte apoptosis in systemic lupus erythematosus.
    Chen W; Lin J
    Clin Rheumatol; 2011 Nov; 30(11):1515-6. PubMed ID: 21927798
    [No Abstract]   [Full Text] [Related]  

  • 20. Altered signaling triggered by ligation of the TCR/CD3 receptor in T lymphocytes from patients with systemic lupus erythematosus: the road from anergy to autoimmunity.
    Blasini AM; Rodríguez MA
    Int Rev Immunol; 2004; 23(3-4):265-72. PubMed ID: 15204088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.